Login to Your Account



Nuvelo Stock Offer: $63.75M For Alfimeprase, Other Drugs

By Randall Osborne


Thursday, February 3, 2005
Proving its financial mettle even without the hoped-for larger alfimeprase deal with Amgen Inc., Nuvelo Inc. priced an offering of 8.5 million shares at $7.50 each to pull down $63.75 million. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription